Related Experiment Video

Updated: Aug 29, 2026

Echocardiographic Assessment Using Subxiphoid-Only Examination for Hypotensive Patients
08:45

Echocardiographic Assessment Using Subxiphoid-Only Examination for Hypotensive Patients

Published on: April 18, 2025

[Arterial hypertension and ischemic heart disease: clinico-echocardiographic aspects]

L A Leshchinskiĭ, B L Mul'tanovskiĭ, S B Ponomarev

    Klinicheskaia Meditsina
    |December 24, 2003
    PubMed

    Insights

    Ischemic heart disease (IHD) and arterial hypertension (AH) are closely linked. AH, especially severe AH, exacerbates IHD by causing myocardial hypertrophy, leading to diastolic dysfunction and reduced heart performance.

    Area of Science:

    • Cardiology
    • Cardiovascular Medicine
    • Clinical Echocardiography

    Background:

    • Ischemic heart disease (IHD) and arterial hypertension (AH) are prevalent cardiovascular conditions.
    • The interplay between IHD and AH, particularly concerning cardiac structural and functional changes, requires further elucidation.
    • Understanding these relationships is crucial for effective patient management.

    Purpose of the Study:

    • To investigate the echocardiographic manifestations of ischemic heart disease (IHD) in patients with varying degrees of arterial hypertension (AH).
    • To explore the association between arterial hypertension and myocardial hypertrophy in the context of ischemic heart disease.
    • To evaluate the impact of combined IHD and AH on left ventricular function and diastolic performance.

    Main Methods:

    • Doppler M-mode echocardiography was performed on 156 male patients with coronarographically verified ischemic heart disease.
    • Patients were stratified into normotensive and mild, moderate, and severe arterial hypertension groups.
    • Echocardiographic parameters were analyzed to assess cardiac structure and function, focusing on left ventricular hypertrophy and diastolic dysfunction.

    Main Results:

    • Echocardiographic findings were often similar between patients with IHD and varying levels of AH, supporting a strong relationship between these conditions.
    • The presence and severity of arterial hypertension correlated with the development and extent of myocardial hypertrophy in patients with IHD.
    • Myocardial hypertrophy, while initially compensatory, was found to promote left ventricular diastolic dysfunction and reduced cardiac performance, particularly in severe AH combined with IHD.

    Conclusions:

    • Arterial hypertension significantly contributes to myocardial hypertrophy in patients with ischemic heart disease.
    • The combination of IHD and severe AH represents a distinct clinical entity with pronounced diastolic dysfunction and impaired cardiac performance.
    • New therapeutic strategies are warranted for managing patients with the combined burden of ischemic heart disease and severe arterial hypertension.

    More Related Videos

    Pulsed Wave Doppler Assessment of Diastolic Dysfunction in the ZSF-1 Rat Model of Pulmonary Hypertension Due to Left Heart Disease08:57

    Pulsed Wave Doppler Assessment of Diastolic Dysfunction in the ZSF-1 Rat Model of Pulmonary Hypertension Due to Left Heart Disease

    Published on: May 22, 2026

    Related Concept Videos

    Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

    Hypertension III: Clinical Manifestations and Diagnostic Studies

    Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
    Hypertension II: Pathophysiology01:29

    Hypertension II: Pathophysiology

    Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
    Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

    Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

    The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
    Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

    Aortic Regurgitation II: Clinical Features and Diagnostic Tests

    Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
    Ischemic Heart Disease: Overview01:17

    Ischemic Heart Disease: Overview

    Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
    Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
    Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

    Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

    Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...